Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.

PubWeight™: 2.01‹?› | Rank: Top 2%

🔗 View Article (PMID 14722525)

Published in J Pediatr on January 01, 2004

Authors

Eleonore D Renner1, Jennifer M Puck, Steven M Holland, Markus Schmitt, Michael Weiss, Michael Frosch, Markus Bergmann, Joie Davis, Bernd H Belohradsky, Bodo Grimbacher

Author Affiliations

1: Department of Infectious Diseases and Clinical Immunology, University Children's Hospital, Dr v. Haunersches Kinderspital, Munich, Germany.

Articles citing this

Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol (2009) 3.13

The hyper-IgE syndromes. Immunol Allergy Clin North Am (2008) 2.19

Inborn errors of human JAKs and STATs. Immunity (2012) 1.90

Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin Immunol (2011) 1.64

Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol (2009) 1.49

Fungal infections in primary immunodeficiencies. Eur J Pediatr (2007) 1.37

Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res (2009) 1.36

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36

The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res (2013) 1.35

DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol (2015) 1.32

Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol (2013) 1.31

Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol (2010) 1.24

An update on the hyper-IgE syndromes. Arthritis Res Ther (2012) 1.23

Chronic granulomatous disease associated with atypical Kawasaki disease. Pediatr Cardiol (2007) 1.18

Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol (2011) 1.14

Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol (2010) 1.12

Genetic Susceptibility to Fungal Infections in Humans. Curr Fungal Infect Rep (2011) 1.04

Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol (2008) 1.03

Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol (2012) 0.98

Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS (2010) 0.98

Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol (2012) 0.95

A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol (2009) 0.90

Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr (2011) 0.89

The hyper-IgE syndrome is not caused by a microdeletion syndrome. Immunogenetics (2007) 0.89

Mendelian genetics of human susceptibility to fungal infection. Cold Spring Harb Perspect Med (2014) 0.89

The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency. Orphanet J Rare Dis (2011) 0.89

No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome. J Clin Immunol (2005) 0.87

Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol (2011) 0.86

Fifty-five-year-old man with chronic yeast infections. Allergy Asthma Proc (2014) 0.81

Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr (2010) 0.80

Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. J Clin Immunol (2015) 0.80

Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation. J Allergy Clin Immunol (2016) 0.79

The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside. World Allergy Organ J (2012) 0.79

Fungal infection of gingiva in a patient with hyperimmunoglobulin-E (Job's) syndrome. J Indian Soc Periodontol (2012) 0.78

Hyper IgE syndrome with umbilical hernia. Indian J Dermatol (2009) 0.78

Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol (2010) 0.78

Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation. Immunol Allergy Clin North Am (2015) 0.78

Hyper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol (2006) 0.76

Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). J Clin Immunol (2010) 0.76

Rapid molecular analysis of the STAT3 gene in Job syndrome of hyper-IgE and recurrent infectious diseases. J Mol Diagn (2010) 0.76

DOCK8 deficiency in six Iranian patients. Clin Case Rep (2016) 0.75

Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol (2016) 0.75

A rare primary immunodeficiency. BMJ Case Rep (2014) 0.75

Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2. Dermatol Clin (2017) 0.75

Psoriasis in hyper IgE syndrome - a case report. Caspian J Intern Med (2013) 0.75

Eosinophilia in an Acutely Limping Child: An Easy Guess of Rare Systemic Aetiology! J Clin Diagn Res (2016) 0.75

Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol (2016) 0.75

CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report. BMC Neurol (2016) 0.75

Hyperimmunoglobulin e syndrome presenting as osteogenesis imperfecta in a 3 year old child. Infect Dis Rep (2013) 0.75

Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis. J Am Acad Dermatol (2015) 0.75

Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndrome. J Neurovirol (2017) 0.75

Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities. J Res Med Sci (2017) 0.75

Articles by these authors

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18

Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest (2008) 9.42

STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17

A higher-level phylogenetic classification of the Fungi. Mycol Res (2007) 7.93

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med (2009) 7.53

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17

Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res (2004) 5.59

Phanerozoic trends in the global diversity of marine invertebrates. Science (2008) 5.36

Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29

A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med (2009) 5.20

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med (2008) 4.76

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity (2006) 4.75

Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52

Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med (2003) 4.46

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature (2002) 4.21

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 4.21

Towards a unified paradigm for sequence-based identification of fungi. Mol Ecol (2013) 4.06

The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. J Infect Dis (2008) 3.84

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83

Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2010) 3.54

Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood (2008) 3.44

Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology (2012) 3.28

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension (2002) 3.23

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol (2009) 3.13

JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med (2013) 3.07

Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2011) 3.05

Chronic granulomatous disease: the European experience. PLoS One (2009) 3.04

HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet (2006) 3.03

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood (2009) 3.00

ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol (2006) 2.99

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol (2007) 2.98

Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet (2004) 2.90

Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med (2012) 2.87

A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med (2006) 2.85

Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med (2007) 2.85

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2013) 2.82

Gastrointestinal involvement in chronic granulomatous disease. Pediatrics (2004) 2.80

An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med (2006) 2.77

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood (2010) 2.77

Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med (2010) 2.61

Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol (2009) 2.58

The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol (2010) 2.55

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis (2008) 2.55

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol (2008) 2.50

Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases. Am J Surg Pathol (2007) 2.48

Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol (2005) 2.45

Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med (2012) 2.44

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33

A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med (2009) 2.30

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26

NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A (2007) 2.25

The hyper-IgE syndromes. Immunol Allergy Clin North Am (2008) 2.19

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med (2006) 2.18

Retracted CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med (2010) 2.17

A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15

Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood (2002) 2.11

Infant colitis--it's in the genes. Lancet (2010) 2.10

ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol (2009) 2.09

Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem (2003) 2.09

Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood (2011) 2.08

Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol (2011) 2.08

Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med (2012) 2.08

Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev (2005) 2.07

Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol (2005) 2.03

Nocardia veterana as a pathogen in North American patients. J Clin Microbiol (2003) 2.03

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA (2010) 2.02

Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet (2005) 1.99

The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat Immunol (2008) 1.97

B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A (2009) 1.95

Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet (2012) 1.94

Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med (2014) 1.94

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood (2013) 1.93

Hyper-IgE syndromes. Immunol Rev (2005) 1.92

Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis (2009) 1.91

Inborn errors of human JAKs and STATs. Immunity (2012) 1.90

Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica (2011) 1.89

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood (2014) 1.88

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta (2004) 1.87

The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol (2008) 1.87

Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet (2007) 1.87

TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol (2005) 1.86

Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol (2011) 1.86

Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res (2003) 1.86

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. J Infect Dis (2010) 1.84

The phenotype of human STK4 deficiency. Blood (2012) 1.84

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood (2008) 1.83